Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • Pfizer’s former chemistry whiz debuts Khartis Therapeutics with $95M for thyroid eye disease pill

Pfizer’s former chemistry whiz debuts Khartis Therapeutics with $95M for thyroid eye disease pill

  • August 12, 2026

Three years after Robert Hoffman sold XinThera to Gilead, the veteran Pfizer chemist has unveiled his latest venture.

Leave A Comment

Fields (*) Mark are Required